FDA Fast-Tracks Plixorafenib for BRAF V600E–Mutated Brain Tumors
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 14, 2026. n Brain tumors, especially high-grade gliomas,
Patient Resources
Resources
Guides on importing specialty medicines, prescription requirements and country rules — written for patients and carers arranging treatment across Southeast Asia and Oceania.
Guides — page 2
-
-
What are the 4 stages of lung cancer?
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 7, 2026. n Lung cancer staging is a
-
First-Line Palbociclib Combination Boosts PFS in HR+/HER2+ mBC – PATINA Findings
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 1, 2026. n Metastatic breast cancer (mBC) remains
-
Sunvozertinib vs Chemo: A PFS Breakthrough in EGFR+ NSCLC
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 25, 2026. n The treatment landscape for EGFR-mutated
-
Atirmociclib and Fulvestrant Together Delay Cancer Progression in HR+/HER2– Cases
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 23, 2026. Advancements in breast cancer treatment continue
-
Healing After Radiation: Is a Nipple-Sparing Mastectomy Possible?
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 20, 2026. n For many years, patients who
-
ESGO 2026 Insights: The Future of Ovarian Cancer Care
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 14, 2026. n The 27th European Congress on
-
Trifluridine/Tipiracil-Associated Neutropenia in Metastatic Colorectal Cancer: What It Means for Treatment Outcomes
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 10, 2026. n Metastatic colorectal cancer (mCRC) remains
-
New Hope for Advanced Prostate Cancer: Enzalutamide and Radium-223 Combination Shows Survival Benefit
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 5, 2026. n Advances in prostate cancer treatment
-
Zongertinib Receives FDA Accelerated Approval for HER2+ NSCLC Treatment
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 28, 2026. n The U.S. Food and Drug
Still have a question?
We reply to every enquiry within one working day.